Suppressed pro-inflammatory response of microglia in CX3CR1 knockout mice

Journal of Neuroimmunology

Volumn 257, Issue 1-2, 2013, Pages 110-115

  Mattison, Hayley A ^a   Nie, Hui ^b   Gao, Huiming ^b   Zhou, Hui ^b   Hong, Jau Shyong ^b   Zhang, Jing ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Alzheimer's disease; Chemokines; Fractalkine; Microglia; Parkinson's disease; Stroke

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR1; FRACTALKINE; NITRIC OXIDE; SMALL INTERFERING RNA; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EMBRYO; IMMUNE RESPONSE; IMMUNOSTIMULATION; MICROGLIA; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; CELL LINE, TRANSFORMED; CELLS, CULTURED; COCULTURE TECHNIQUES; INFLAMMATION MEDIATORS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; NEURONS; RECEPTORS, CHEMOKINE;

EID: 84875811005     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.02.008     Document Type: Article

References (27)

1. Austin C.P., Battey J.F., Bradley A., Bucan M., Capecchi M., Collins F.S., Dove W.F., Duyk G., Dymecki S., Eppig J.T., Grieder F.B., Heintz N., Hicks G., Insel T.R., Joyner A., Koller B.H., Lloyd K.C., Magnuson T., Moore M.W., Nagy A., Pollock J.D., Roses A.D., Sands A.T., Seed B., Skarnes W.C., Snoddy J., Soriano P., Stewart D.J., Stewart F., Stillman B., Varmus H., Varticovski L., Verma I.M., Vogt T.F., von Melchner H., Witkowski J., Woychik R.P., Wurst W., Yancopoulos G.D., Young S.G., Zambrowicz B. The knockout mouse project. Nat. Genet. 2004, 36:921-924.
2. Barbaric I., Miller G., Dear T.N. Appearances can be deceiving: phenotypes of knockout mice. Brief. Funct. Genomic. Proteomic. 2007, 6:91-103.
3. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., Huang D., Kidd G., Dombrowski S., Dutta R., Lee J.C., Cook D.N., Jung S., Lira S.A., Littman D.R., Ransohoff R.M. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 2006, 9:917-924.
4. Chen S.H., Wu H.M., Ossola B., Schendzielorz N., Wilson B.C., Chu C.H., Chen S.L., Wang Q., Zhang D., Qian L., Li X., Hong J.S., Lu R.B. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage. Br. J. Pharmacol. 2012, 165:494-505.
5. Cook D.N., Chen S.C., Sullivan L.M., Manfra D.J., Wiekowski M.T., Prosser D.M., Vassileva G., Lira S.A. Generation and analysis of mice lacking the chemokine fractalkine. Mol. Cell. Biol. 2001, 21:3159-3165.
6. Dénes A., Ferenczi S., Halasz J., Kornyei Z., Kovacs K.J. Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. J. Cereb. Blood Flow Metab. 2008, 28:1707-1721.
7. Donnelly D.J., Longbrake E.E., Shawler T.M., Kigerl K.A., Lai W., Tovar C.A., Ransohoff R.M., Popovich P.G. Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages. J. Neurosci. 2010, 31:9910-9922.
8. Fredholm B.B., Chen J.F., Masino S.A., Vaugeois J.M. Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. Annu. Rev. Pharmacol. Toxicol. 2005, 45:385-412.
9. Fuhrmann M., Bittner T., Jung C.K., Burgold S., Page R.M., Mitteregger G., Haass C., LaFerla F.M., Kretzschmar H., Herms J. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nat. Neurosci. 2010, 13:411-413.
10. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 1982, 126:131-138.
11. Harrison J.K., Jiang Y., Chen S., Xia Y., Maciejewski D., McNamara R.K., Streit W.J., Salafranca M.N., Adhikari S., Thompson D.A., Botti P., Bacon K.B., Feng L. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:10896-10901.
12. Horvath R.J., Nutile-McMenemy N., Alkaitis M.S., Deleo J.A. Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures. J. Neurochem. 2008, 107:557-569.
13. Huang D., Shi F.D., Jung S., Pien G.C., Wang J., Salazar-Mather T.P., He T.T., Weaver J.T., Ljunggren H.G., Biron C.A., Littman D.R., Ransohoff R.M. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 2006, 20:896-905.
14. Jung S., Aliberti J., Graemmel P., Sunshine M.J., Kreutzberg G.W., Sher A., Littman D.R. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 2000, 20:4106-4114.
15. Lee S., Varvel N.H., Konerth M.E., Xu G., Cardona A.E., Ransohoff R.M., Lamb B.T. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. Am. J. Pathol. 2010, 177:2549-2562.
16. Liu Z., Condello C., Schain A., Harb R., Grutzendler J. CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-beta phagocytosis. J. Neurosci. 2010, 30:17091-17101.
17. Lloyd K.C. A knockout mouse resource for the biomedical research community. Ann. N. Y. Acad. Sci. 2011, 1245:24-26.
18. Lyons A., Lynch A.M., Downer E.J., Hanley R., O'Sullivan J.B., Smith A., Lynch M.A. Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attenuates microglial activation in vivo and in vitro. J. Neurochem. 2009, 110:1547-1556.
19. Mizuno T., Kawanokuchi J., Numata K., Suzumura A. Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res. 2003, 979:65-70.
20. Nishiyori A., Minami M., Ohtani Y., Takami S., Yamamoto J., Kawaguchi N., Kume T., Akaike A., Satoh M. Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia?. FEBS Lett. 1998, 429:167-172.
21. Ransohoff R.M., Cardona A.E. The myeloid cells of the central nervous system parenchyma. Nature 2010, 468:253-262.
22. Ransohoff R.M., Perry V.H. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 2009, 27:119-145.
23. Wu X., Chen P.S., Dallas S., Wilson B., Block M.L., Wang C.C., Kinyamu H., Lu N., Gao X., Leng Y., Chuang D.M., Zhang W., Lu R.B., Hong J.S. Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int. J. Neuropsychopharmacol. 2008, 11:1123-1134.
24. Zahniser N.R., Simosky J.K., Mayfield R.D., Negri C.A., Hanania T., Larson G.A., Kelly M.A., Grandy D.K., Rubinstein M., Low M.J., Fredholm B.B. Functional uncoupling of adenosine A(2A) receptors and reduced response to caffeine in mice lacking dopamine D2 receptors. J. Neurosci. 2000, 20:5949-5957.
25. Zhang W., Wang T., Pei Z., Miller D.S., Wu X., Block M.L., Wilson B., Zhou Y., Hong J.S., Zhang J. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J. 2005, 19:533-542.
26. Zhang W., Dallas S., Zhang D., Guo J.P., Pang H., Wilson B., Miller D.S., Chen B., McGeer P.L., Hong J.S., Zhang J. Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein. Glia 2007, 55:1178-1188.
27. Zhou Y., Wang Y., Kovacs M., Jin J., Zhang J. Microglial activation induced by neurodegeneration: a proteomic analysis. Mol. Cell. Proteomics 2005, 4:1471-1479.